A Phase 1/2 Study of MEDI4276 in Adults Subjects With Select HER2-expressing Advanced Solid Tumors.
NCT02576548
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
47
Enrollment
INDUSTRY
Sponsor class
Conditions
HER2 Expressing Breast or Gastric/Stomach Cancers
Interventions
BIOLOGICAL:
MEDI4276
Sponsor
MedImmune LLC